Table 3.

Core performance measures for eligible myocardial infarction patients according to documentation of ischaemic symptoms.

Core Performance Measures	Documented ischaemic Symptoms		P value
	No	Yes
	N treated of eligible (%)	N treated of eligible (%)
Admission Medications and Treatment (%)
Aspirin in 24 hours	180 of 202 (89%)	1,745 of 1810 (96%)	<0.001
Beta-blockers in 24 hours	127 of 165 (77%)	1,449 of 1,658 (90%)	<0.001
Acute reperfusion in eligible ST Elevation MI patients	4 of 58 (7%)	447 of 773 (58%)	<0.001
In-Hospital Death (%)	32 of 217 (14%)	50 of 1,877 (3%)	<0.001
Discharge Medications and Treatment (%)
Aspirin at discharge	144 of 165 (87%)	1,618 of 1,742 (93%)	0.009
Beta-blocker	128 of 158 (81%)	1,529 of 1,678 (91%)	<0.001
ACE inhibitor for left ventricular systolic dysfunction	30 of 45 (67%)	314 of 392 (80%)	0.037
Statin drug
LDL>70 mg/dL (>1.81 mmol/L)	53 of 71 (75%)	1,279 of 1,511 (85%)	<0.001
LDL>100 mg/dL (>2.59 mmol/L)	27 of 38 (71%)	933 of 960 (97%)	<0.001
Smoking Cessation Counseling (in smokers, n=2191)	22 of 48 (46%)	420 of 632 (66%)	0.004